World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
44307
World Ranking
7881
National Ranking
449

Overview

Ulrich Germing is affiliated with Heinrich Heine University Düsseldorf in Germany. The primary field of research is Medicine, with a substantial focus on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health, and Oncology. The researcher has contributed extensively to the understanding of hematological diseases and related medical fields.

Frequent publication venues for Germing's work include:

  • Blood
  • HemaSphere
  • Leukemia
  • Cancers
  • Annals of Hematology

Among the recent papers authored or co-authored by Germing are:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms," 2022, Leukemia
  • "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes," 2022, NEJM Evidence
  • "Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes," 2020, New England Journal of Medicine
  • "Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes," 2023, Journal of Clinical Oncology
  • "Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes," 2023, Blood

Germing collaborates frequently with several researchers, including:

  • Uwe Platzbecker
  • Pierre Fenaux
  • Guillermo Sanz
  • Valeria Santini
  • Norbert Gattermann

The main topics covered in Germing's work focus on hematologic disorders and therapies, including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Hematopoietic Stem Cell Transplantation
  • Chronic Myeloid Leukemia Treatments
  • Histone Deacetylase Inhibitors Research
  • Lymphoma Diagnosis and Treatment

In addition to peer-reviewed articles, Germing has contributed to book publications. Notably, one title published by Frontiers Media in 2023 titled "Hybrid or Mixed Myelodysplastic / Myeloproliferative Disorders: Current Trends in Diagnosis and Treatment" is part of this scholarly output.

Best Publications

  • Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz

  • Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

    Luca Malcovati;Ulrich Germing;Andrea Kuendgen;Matteo G. Della Porta

  • Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

    Pierre Fenaux;Ghulam J. Mufti;Eva Hellström-Lindberg;Valeria Santini

  • IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication

    Peter Paschka;Richard F. Schlenk;Verena I. Gaidzik;Marianne Habdank

  • New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

    Detlef Haase;Ulrich Germing;Julie Schanz;Michael Pfeilstöcker

  • Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

    Luca Malcovati;Eva Hellström-Lindberg;David Bowen;Lionel Adès

  • Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

    Stephanie Kruetzmann;M. Manuela Rosado;Holger Weber;Ulrich Germing

  • Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

    Michael Lübbert;Stefan Suciu;Liliana Baila;Björn Hans Rüter

  • Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

    Peter Valent;Hans-Peter Horny;John M. Bennett;Christa Fonatsch

  • New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

    Julie Schanz;Heinz Tüchler;Francesc Solé;Mar Mallo

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    Pierre Fenaux;Pierre Fenaux;Uwe Platzbecker;Ghulam J. Mufti;Guillermo Garcia-Manero

  • Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

    Jan Krönke;Richard F. Schlenk;Kai-Ole Jensen;Florian Tschürtz

  • Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

    Ghulam J. Mufti;John M. Bennett;Jean Goasguen;Barbara J. Bain

  • Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

    Ulrich Germing;Norbert Gattermann;Corinna Strupp;Manuel Aivado

  • Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

    Aul C;Gattermann N;Heyll A;Germing U

  • Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.

    Andrea Kuendgen;Corinna Strupp;Manuel Aivado;Alf Bernhardt

  • Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

    Luca Malcovati;Matteo G Della Porta;Corinna Strupp;Ilaria Ambaglio

  • Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

    Esperanza Such;Ulrich Germing;Luca Malcovati;José Cervera

  • Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

    Uwe Platzbecker;Ulrich Germing;Katharina S Götze;Philipp Kiewe

Frequent Co-Authors

Norbert Gattermann
Norbert Gattermann Heinrich Heine University Düsseldorf
Aristoteles Giagounidis
Aristoteles Giagounidis Heinrich Heine University Düsseldorf
Michael Lübbert
Michael Lübbert University of Freiburg
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Peter Valent
Peter Valent Medical University of Vienna
Arnold Ganser
Arnold Ganser Hannover Medical School
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Theo de Witte
Theo de Witte Radboud University
Eva Hellström-Lindberg
Eva Hellström-Lindberg Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine or healthcare doesn’t always mean following the traditional path of medical school. Today, there is a wide range of online degree options for those interested in healthcare careers that offer flexibility and more affordable tuition.

For those interested in hospital or clinic management, cheapest mha programs allow you to earn a master's in healthcare administration online without breaking the bank. If you’re aiming for advanced nursing roles, there are also least expensive dnp programs available, helping experienced nurses take the next step in their career.

Pharmacy is another field that offers online opportunities. If you’re concerned about tuition, exploring online pharmacy school cost can help you find Doctorate of Pharmacy programs that fit your budget. For those looking at data and management roles within healthcare, an him associate degree online is a cost-effective entry point.

These alternative pathways make it easier to launch or advance a career in healthcare, no matter your starting point or financial situation.

Best Scientists Citing Ulrich Germing

Trending Scientists

Recently Published Articles